Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2018, Article ID 4789196, 11 pages
https://doi.org/10.1155/2018/4789196
Research Article

Pharmacokinetics of Eight Flavonoids in Rats Assayed by UPLC-MS/MS after Oral Administration of Drynariae rhizoma Extract

1Key Laboratory of Chinese Materia Medica, College of Pharmacy, College of Jiamusi, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, China
2Key Laboratory of Photochemistry Biomaterials and Energy Storage Materials of Heilongjiang Province, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin 150025, China
3Pharmacy Department, Harbin Hospital of Traditional Chinese Medicine, Harbin 150076, China
4Crop Academy of Heilongjiang University, Harbin 150080, China

Correspondence should be addressed to Fang Geng; moc.361@0891gnafgneg and Ning Zhang; moc.361@4540gningnahz

Received 16 September 2018; Revised 16 November 2018; Accepted 2 December 2018; Published 18 December 2018

Academic Editor: Antony C. Calokerinos

Copyright © 2018 Zhan-Ling Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Chinese Pharmacopoeia Commission, Pharmacopoeia of the People’s Republic of China, vol. 1, Beijing, China, 2015.
  2. L. L. Liu, Q. U. Wei, and J. Y. Liang, “Progress on chemical constituents and biological activities of Drynaria fortunei,” Strait Pharmaceutical Journal, vol. 24, no. 1, pp. 4–7, 2012. View at Google Scholar
  3. X. Qiao, X. Lin, and Y. Liang, Comprehensive Chemical Analysis of the Rhizomes of Drynaria fortunei by Orthogonal, Pre-Separation and Liquid Chromatography Mass Spectrometry, Springer-Verlag, Berlin, Germany, 2014.
  4. S. H. Song, Y. K. Zhai, C. Q. Li et al., “Effects of total flavonoids from Drynariae rhizoma prevent bone loss in vivo and in vitro,” Bone Reports, vol. 5, pp. 262–273, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Yang, Y. H. Sun, and Z. J. LV, “Effect of Rhizoma Drynariae flavones on alveolar bone quality in patients with osteoporosis,” China Journal of Oral and Maxillofacial Surgery, vol. 16, no. 1, pp. 34–40, 2017. View at Google Scholar
  6. H. C. Kuo, H. C. Chang, W. C. Lan, F. H. Tsai, J. C. Liao, and C. R. Wu, “Protective effects of Drynaria fortunei against 6-hydroxydopamine-induced oxidative damage in B35 cells via the PI3K/AKT pathway,” Food and Function, vol. 5, no. 8, pp. 1956–1965, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. W. Jiang, J. Q. Zeng, and F. Huang, “Effects of flavonoids of rhizoma Drynariae on tibia distraction osteogenesis efficacy in rat model,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 33, no. 2, pp. 661–663, 2018. View at Google Scholar
  8. S. Song, Z. Gao, X. Lei et al., “Total flavonoids of Drynariae rhizoma prevent bone loss induced by hindlimb unloading in rats,” Molecules, vol. 22, no. 7, p. 1033, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Guo, Q. Du, and J. F. Rebhun, “Chinese herbal combination of epimedium, Drynariae rhizoma, and salvia miltiorrhiza extracts prevents osteoporosis in ovariectomized rats,” International Journal of Clinical and Experimental Medicine, vol. 10, no. 7, pp. 10607–10615, 2017. View at Google Scholar
  10. G. Zhang, F. Geng, T. Zhao et al., “Biocompatible symmetric Na-ion microbatteries with sphere-in-network heteronanomat electrodes realizing high reliability and high energy density for implantable bioelectronics,” ACS Applied Materials and Interfaces, vol. 10, no. 49, pp. 42268–42278, 2018. View at Publisher · View at Google Scholar
  11. N. Zhang, Z. Hu, Z. Zhang et al., “Protective role of naringenin against Aβ25-35-caused damage via ER and PI3K/Akt-Mediated pathways,” Cellular and Molecular Neurobiology, vol. 38, no. 2, pp. 549–557, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Y. Yang, T. Kuboyama, K. Kazuma, K. Konno, and C. Tohda, “Active constituents from Drynaria fortunei rhizomes on the attenuation of Aβ25-35-induced axonal atrophy,” Journal of Natural Products, vol. 78, no. 9, pp. 2297–2300, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Wang, J. Liu, A. Zhang, X. Zhou, and H. Sun, “Serum pharmacochemistry of TCM screening the bioactive components from moutan cortex,” in Serum Pharmacochemistry of Traditional Chinese Medicine, pp. 287–302, Academic Press, Cambridge, MA, USA, 2017, Chapter 21. View at Publisher · View at Google Scholar · View at Scopus
  14. X. H. Li, Z. L. Xiong, S. Lu, Y. Zhang, and F. M. Li, “Pharmacokinetics of naringin and its metabolite naringenin in rats after oral administration of Rhizoma Drynariae extract assayed by UPLC-MS/MS,” Chinese Journal of Natural Medicines, vol. 8, no. 1, pp. 40–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Xu, Z. Xu, Q. Xu et al., “UPLC-MS/MS method for the determination of 14 compounds in rat plasma and its application in a pharmacokinetic study of orally administered xiaoyao powder,” Molecules, vol. 23, no. 10, p. 2514, 2018. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Fang, Y. Wang, Y. Ma, W. Su, Y. Bai, and P. Zhao, “A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma,” Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 2, pp. 454–459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Ishii, T. Furuta, and Y. Kasuya, “Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 704, no. 1-2, pp. 299–305, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Wang, Q. Wang, and M. E. Morris, “Pharmacokinetic interaction between the flavonoid luteolin and γ-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters,” AAPS Journal, vol. 10, no. 1, pp. 47–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Yin, X. Chen, F. Han, Z. Shen, W. Cheng, and K. Bi, “LC-MS determination and pharmacokinetic study of luteolin-7-O-β-d-glucoside in rat plasma after administration of the traditional Chinese medicinal preparation kudiezi injection,” Chromatographia, vol. 67, no. 11-12, pp. 961–965, 2008. View at Publisher · View at Google Scholar · View at Scopus